Navigation Links
Sanofi-aventis and Regeneron Expand Strategic Antibody Collaboration
Date:11/10/2009

PARIS, and TARRYTOWN, N.Y., Nov. 10 /PRNewswire-FirstCall/ -- Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced today that they have entered into agreements to expand and extend their existing global collaboration to discover, develop, and commercialize fully-human therapeutic monoclonal antibodies.

Sanofi-aventis will increase its annual funding commitment from $100M to $160 million beginning in 2010, and the research funding will now extend through 2017. The companies aim to advance an average of four to five antibodies into clinical development each year. In addition to its VelocImmune(®) technology, Regeneron will contribute to the collaboration its next generation technologies related to antibody generation.

Sanofi-aventis has an option to extend the discovery program for up to an additional three years for further antibody development and preclinical activities. The amendments announced today do not change the financial terms of the November 2007 agreement governing the development and commercialization of antibody drug candidates arising from the discovery collaboration.

"The first two years of our collaboration with sanofi-aventis have been extremely productive, with five VelocImmune(® )human antibodies in or entering clinical development," commented Leonard S. Schleifer, M.D., Ph.D., President and Chief Executive Officer of Regeneron. "The expansion of our collaboration provides even greater resources over a longer time horizon and will boost our efforts to build a deep pipeline of new human antibody product candidates. Sanofi-aventis is an ideal partner with the expertise and glo
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Vical Licensee Sanofi-aventis Initiates Phase 3 Trial to Reduce Amputations
2. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
3. Sanofi-aventis Stands Behind the Safety of Lantus(R)
4. Fovea Pharmaceuticals to be Acquired by sanofi-aventis
5. Sanofi-aventis and Merrimack Pharmaceuticals Enter Into a Worldwide Collaboration and Licensing Agreement on MM-121, an Anti-ErbB3 Monoclonal Antibody
6. Prasco Enters into Agreements with sanofi-aventis U.S. to Provide Sales Support and Distribution Services for Authorized Generic Versions Under the Winthrop Label in U.S.
7. Bayer and Regeneron Dose First Patient in Second Phase 3 Study for VEGF Trap-Eye in Wet Age-Related Macular Degeneration
8. Bayer and Regeneron Extend Development Program for VEGF Trap-Eye to Include Central Retinal Vein Occlusion
9. Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
10. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
11. Regeneron Reports Third Quarter 2009 Financial and Operating Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)...  BioElectronics Corporation (OTC Pink: BIEL), the maker of ... featuring the use of ActiPatch®, its novel musculoskeletal pain ... Congress of the European Pain Federation EFIC®, ... The Company will also be exhibiting at the Congress ... , department clinical and experimental rheumatology from the University ...
(Date:8/27/2015)... 2015 The Elekta Linac-based Brain ... Boston on July 9th for its inaugural ... more fully exploit the potential of advances in linear ... "As an established provider of sophisticated cancer ... a leadership role - in collaboration with its clinical ...
(Date:8/27/2015)... SOUTH SAN FRANCISCO, Calif. , Aug. 27, ... developing Probody™ therapeutics for the treatment of cancer, ... previously a member of the company,s Board of ... Humphrey formerly led immuno-oncology at Eli Lilly and ... (ipilmumab), the first FDA approved checkpoint inhibitor, at ...
Breaking Medicine Technology:BioElectronics Selected to Present its Pain Research and Devices at the European Pain Federation Conference 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 2New Elekta Consortium to Push Frontiers of Linear Accelerator-Based Stereotactic Radiation Therapy for the Brain 3Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 2Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer 3
... Jones Sustainability Indexes for the Sixth... -- ABBOTT PARK, Ill., Nov. 8, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... ""; BitlyCB.alertResponse = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... 8, 2010 Roche (SIX: RO, ROG; OTCQX: RHHBY) ... Link, a versatile online resource that helps simplify and ... The web-based application gives patients who self-test ... report their test results and gives doctors a single, ...
Cached Medicine Technology:Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 2Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 3Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 4Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 5Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 6Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 7Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 8Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 9Abbott Remains on the Dow Jones Sustainability Indexes for the Sixth Consecutive Year in Recognition of Leading Corporate Citizenship Performance 10Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients 2Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients 3Roche Introduces CoaguChek Link Web Resource to Streamline Anticoagulation Management for Doctors and Patients 4
(Date:8/27/2015)... ... ... Thriveology Founders, Dr. Carly Letzt Carney and Dr. Mark Carney announced today that ... on Saturday, August 29, 2015 at the Marriott DTC, 4900 S. Syracuse Street, Denver, ... will present a two part seminar entitled, “How to Thrive as You Age & ...
(Date:8/27/2015)... Michigan (PRWEB) , ... August 27, 2015 , ... On ... returned for the second year as sponsor of the “Music With A Mission” benefit ... raise money for music education programs in the underfunded school districts of Mendon and ...
(Date:8/27/2015)... , ... August 27, 2015 , ... The Naderi Center ... be offering Kybella, a cutting-edge, noninvasive procedure to improve submental fat. The first ... provides permanent results without surgery. Dr. Kulak is the only Board Certified surgeon ...
(Date:8/27/2015)... Mirada, CA (PRWEB) , ... August 27, 2015 , ... ... Agency, into its La Tijera Clinic in Los Angeles. Licensed to practice Chinese Needle ... an emphasis on neuromuscular injuries and diseases. Dr. Priebe also practices in Healthpointe’s La ...
(Date:8/27/2015)... ... ... In addition to its existing Doctor of Philosophy in Leadership and Doctor of ... campus in Reading: Doctor of Nursing Practice. , Alvernia’s Doctor of Nursing Practice ... the highest level of clinical nursing practice. , “Our vision is to graduate ...
Breaking Medicine News(10 mins):Health News:Internationally-renowned Naturopathic Doctor and Chiropractor Team up to Reveal Secrets of Avoiding Disease 2Health News:Best Drug Rehabilitation Interviews Madd Hoss Jackson at the 2015 "Music With A Mission" Benefit Concert 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 2Health News:Noninvasive Double Chin Elimination Now Available in Herndon and Chevy Chase 3Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Alvernia University Now Offering Three Doctoral Degree Programs 2
... Healthy, new heart cells have been generated by animals ... derived from cardiac biopsies or "cardiospheres," according to research ... and Biomedical Sciences. , The research is being ... the American Heart Association in Orlando. , The UB ...
... November 15, 2011 -- A Ben-Gurion University of the ... fertility, producing normal sperm from mouse cells. "This ... who cannot generate sperm and/or pre-pubertal cancer patients at ... and cannot cryopreserve sperm as in adult patients," explains ...
... , MONDAY, Nov. 14 (HealthDay News) -- Researchers have homed ... involved in "chemo brain," the memory problems and other impairments ... to research in the November issue of the Archives ... involved in planning, attention and memory performance were less robust ...
... TUESDAY, Nov. 15 (HealthDay News) -- Patients with cardiovascular disease ... help lower their cholesterol get no additional clinical benefit, a ... HDL cholesterol -- the good cholesterol -- and decrease triglycerides, ... reduce the risk of heart attack, stroke or death, the ...
... Among patients who experienced an ischemic stroke, systolic blood ... than 140 mm Hg, were associated with an increased risk ... November 16 issue of JAMA , a theme issue ... to coincide with the American Heart Association Scientific Sessions. ...
... collect ,near real-time, data about whether people are having ... received the 2009-10 swine flu vaccination in Scotland, researchers ... of safety to future vaccination campaigns. In addition, the ... exposed to the vaccine. The project,s report has just ...
Cached Medicine News:Health News:New heart cells increase by 30 percent after stem cell infusion 2Health News:Breast Cancer Chemo Tied to Memory Troubles 2Health News:Breast Cancer Chemo Tied to Memory Troubles 3Health News:No Benefit From Niacin for Heart Patients in Study 2Health News:No Benefit From Niacin for Heart Patients in Study 3Health News:Study evaluates 'normal range' systolic bp levels after ischemic stroke and risk of recurrent stroke 2Health News:New hi-tech survey accelerates collection of vaccination data 2
Provides a perfect ring reference to the corneal surface, most useful for the wound closure evaluation. Shaft angled 35 degrees. Round knurled handle with dull finish....
...
Stainless steel tray for sterilizing instruments....
For sterilizing, carrying and storage of a Storz diamond knife and barrel gauge....
Medicine Products: